ALLHAT says diuretics are better; ANBP2 says ACEs are better - Can we resolve the differences?

Cleveland Clinic Journal of Medicine

Volumn 71, Issue 2, 2004, Pages 145-150

  Vidt, Donald G ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMLODIPINE BESYLATE; ATENOLOL; CHLORTALIDONE; CLONIDINE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; DOXAZOSIN; ENALAPRIL MALEATE; HYDRALAZINE; HYDROCHLOROTHIAZIDE; LISINOPRIL; RESERPINE;

ADD ON THERAPY; ARTICLE; BLOOD PRESSURE REGULATION; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEATH; DRUG WITHDRAWAL; HEART FAILURE; HEART INFARCTION; HUMAN; HYPERTENSION; ISCHEMIC HEART DISEASE; MEDICAL DECISION MAKING; METHODOLOGY; MONOTHERAPY; RACE DIFFERENCE; RANDOMIZED CONTROLLED TRIAL; SAMPLE SIZE; TREATMENT OUTCOME;

EID: 1342310779     PISSN: 08911150     EISSN: None     Source Type: Journal    
DOI: 10.3949/ccjm.71.2.145     Document Type: Article

References (5)

1. The ALLHAT Officers and Coordinators for the ALLHAT Collaborative Research Group. Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic. JAMA 2002; 288:2981-2997.
2. Wing LM, Reid CM, Ryan P, et al. A comparison of outcomes with angiotensin-converting-enzyme inhibitors and diuretics for hypertension in the elderly. N Engl J Med 2003; 348:583-592.
3. Vidt DG. The ALLHAT Trial. Diuretics are still the preferred initial drugs for high blood pressure. Cleve Clin J Med 2003; 70:263-269.
4. Vidt DG. Alpha-blockers and congestive heart failure: early termination of an arm of the ALLHAT trial. Cleve Clin J Med 2000; 67:429-433.
5. The seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. JAMA 2003; 289:2560-2572.